Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGLAXO
resources
GLAXO

Glaxosmithkline Pharmaceuticals Ltd.

NSE: GLAXO
BSE: 500660
Sector: Healthcare
Industry: Pharmaceuticals
2,435.50-4.9 (-0.20%)
10 Jul, 12:00 AM

Annual Reports and Financial Documents

Glaxosmithkline Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results——————
Conference Calls—————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Glaxosmithkline Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    As per attachment
  • AGM30 Jun 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    As per attachment
  • AGM30 Jun 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    As per attachment
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    As per attachment
  • General25 Jun 2026
    Disclosure Under Regulation 30
    As per attachment
  • Newspaper Publication9 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  • General8 Jun 2026
    Letter For Website Link For Annual Report
    As per attachment
  • AGM5 Jun 2026
    AGM Notice For 2025-26
    As per attachment
  • Business Responsibility and Sustainability Reporting (BRSR)5 Jun 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    BRSR Report for 2025-26
  • Reg. 34 (1) Annual Report5 Jun 2026
    Reg. 34 (1) Annual Report.
    Annual Report for 2025-26
  • Newspaper Publication2 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  • Newspaper Publication29 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  • Change in Management29 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Resignation of Dr. Simrat Sohal as Compliance officer of the Company
  • Reg.24(A)-Annual Secretarial Compliance26 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Compliance Secretarial Report for year ended March 2026
  • Analyst / Investor Meet18 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  • Newspaper Publication14 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    As per attachment
  • Analyst / Investor Meet13 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    As per attachment
  • Press Release / Media Release13 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    As per Attachment
  • Analyst / Investor Meet13 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investor Presentation
  • Dividend13 May 2026
    Corporate Action-Board approves Dividend
    As per attachment

Frequently Asked Questions

Where can I download the annual report of Glaxosmithkline Pharmaceuticals Ltd.?
Annual reports of Glaxosmithkline Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Glaxosmithkline Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Glaxosmithkline Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Glaxosmithkline Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Glaxosmithkline Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Glaxosmithkline Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Glaxosmithkline Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Glaxosmithkline Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Glaxosmithkline Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Glaxosmithkline Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Glaxosmithkline Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Glaxosmithkline Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Glaxosmithkline Pharmaceuticals Ltd. is INE159A01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Glaxosmithkline Pharmaceuticals Ltd. listed?
Glaxosmithkline Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is GLAXO and the BSE code is -.
Where can I find the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Glaxosmithkline Pharmaceuticals Ltd. on Sharpely?
Share price data for Glaxosmithkline Pharmaceuticals Ltd. is updated as of 10 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.